In the present paper, we demonstrated that FSCN1 levels are measurable in the bloodstream of ACC patients and are significantly higher than those measured in healthy non-tumoral subjects, reflecting the higher intratumoral levels of FSCN1 compared with normal adrenals (6, 7). The gene discussed is FSCN1; the disease is adrenal cortex carcinoma.